Meru Health Program for Cancer Patients With Depression and Anxiety

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary objective of this study is to evaluate clinical outcomes among people with cancer who participate in a 12-week therapist-supported digital mental health intervention (DMHI) called the Meru Health Program (MHP). Study participants (N=20) will be referred to the MHP through the Cancer Support Community (CSC) Helpline and network of Gilda\'s Club locations. The main outcomes will be depression symptoms, anxiety symptoms, health-related quality of life (HRQoL), intervention adherence, and intervention satisfaction. The secondary objective will be to determine the acceptability of the screening and referral process from the CSC networks into the MHP. Data pertaining to implementability will be collected from study participants, MHP clinicians, and CSC staff.
Epistemonikos ID: 00b8fa3cb59483bb38500acb948582bb55f93cf0
First added on: May 14, 2024